JAMA Network Open: Telehealth Treatment for Opioid Use Disorder During Pregnancy

JAMA Network Open: Telehealth Treatment for Opioid Use Disorder During Pregnancy

Research found that a majority of pregnant people remained engaged in telehealth-enabled opioid use disorder (OUD) care, with most carrying to term. The researchers conducted a cohort study assessing the efficacy of a low-barrier, multistate, telehealth-based addiction treatment program in the US. They used EHR data to identify pregnant patients, 18 and over, diagnosed with OUD and receiving buprenorphine or buprenorphine and naloxone treatment between January 1, 2018, and December 31, 2022. The study also showed that patients who became pregnant once established in care through telehealth were more likely to continue virtual care.